CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer

Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer

(2010) S. Y. Park et al.   CLINICAL CANCER RESEARCH

Cancer Stem Cells and Self-renewal

(2010) C. A. O'Brien et al.   CLINICAL CANCER RESEARCH

CSPG4 in Cancer: Multiple Roles

(2010) X. Wang et al.   CURRENT MOLECULAR MEDICINE

Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse

(2010) Feng-Ju Huang et al.   DEVELOPMENTAL BIOLOGY

Triple-negative breast cancer--current status and future directions

(2009) O. Gluz et al.   ANNALS OF ONCOLOGY

Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition

(2009) J. Yang et al.   CANCER RESEARCH

MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

(2009) Ann F. Chambers   CANCER RESEARCH

Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?

(2009) Fausto Petrelli et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Phosphorylation of α6-Tubulin by Protein Kinase Cα Activates Motility of Human Breast Cells

(2009) Thushara P. Abeyweera et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Breast Cancer Stem Cells and Intrinsic Subtypes: Controversies Rage On

(2009) Harikrishna Nakshatri et al.   Current Stem Cell Research & Therapy

A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs

(2008) Mihaela Crisan et al.   Cell Stem Cell

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis

(2008) Christine E. Eyler et al.   JOURNAL OF CLINICAL ONCOLOGY

The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling

(2008) M Chekenya et al.   ONCOGENE